Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Application of Thoracic Aortic Calcium Scoring for Adverse Clinical Outcome Risk in Elderly Patients with Left Ventricular Hypertrophy

  • Cho, In-Jeong (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Chang, Hyuk-Jae (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Lee, Sang-Eun (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Shim, Chi Young (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Hong, Geu-Ru (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Chung, Namsik (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine)
  • Received : 2017.01.04
  • Accepted : 2017.07.19
  • Published : 2017.11.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Left ventricular hypertrophy (LVH) is associated with poor cardiovascular outcomes. Heavy aortic calcification exacerbates arterial stiffness, which consequently heightens left ventricular (LV) afterload. We assessed the usefulness of aortic calcification for predicting adverse cardiovascular outcomes and to determine whether the relationship, if any, differed as a function of LVH. Methods: The analytic sample was comprised of a total of 487 individuals 65 years of age or older. Thoracic aortic calcium score (TACS) was measured by coronary computed tomography, and patients were stratified according to the median (TACS, $446mm^3$). LVH obtained from echocardiography was defined as LV mass index >$115g/m^2$ for men and >$95g/m^2$ for women. Cox regression reporting hazard ratios (HRs) with 95% confidence intervals (CIs) was performed to predict the risk for the composite study endpoint, defined as cardiac death, admission for heart failure, obstructive coronary artery disease (CAD) requiring revascularization, or stroke. Results: A total of 39 composite events (8.0%) occurred during a median follow-up of 65 months (interquartile range [IQR], 17-89 months). For those with LVH, the concurrent presence of high TACS appeared to be an independent predictor (HR, 4.51; 95% CI, 1.71-11.88; p=0.002) for the composite study endpoint. Other combined LVH and TACS subgroups were not associated with significant factors for predicting the composite study endpoint (p>0.050, all). Conclusion: TACS provides robust predictive utility for a composite of cardiovascular events and cardiac death in persons with LVH. This finding was less pronounced in those with a relatively healthy myocardium, defined by the absence of LVH.

Keywords

Acknowledgement

Supported by : National Research Foundation of Korea (NRF)

References

  1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6. https://doi.org/10.1056/NEJM199005313222203
  2. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000;35:580-6. https://doi.org/10.1161/01.HYP.35.2.580
  3. Sundstrom J, Lind L, Arnlov J, Zethelius B, Andren B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation 2001;103:2346-51. https://doi.org/10.1161/01.CIR.103.19.2346
  4. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000;35:569-82. https://doi.org/10.1016/S0735-1097(99)00630-0
  5. Nadruz W. Myocardial remodeling in hypertension. J Hum Hypertens 2015;29:1-6. https://doi.org/10.1038/jhh.2014.36
  6. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013;62:263-71. https://doi.org/10.1016/j.jacc.2013.02.092
  7. Eisen A, Tenenbaum A, Koren-Morag N, et al. Calcification of the thoracic aorta as detected by spiral computed tomography among stable angina pectoris patients: association with cardiovascular events and death. Circulation 2008;118:1328-34. https://doi.org/10.1161/CIRCULATIONAHA.107.712141
  8. Wong ND, Gransar H, Shaw L, et al. Thoracic aortic calcium versus coronary artery calcium for the prediction of coronary heart disease and cardiovascular disease events. JACC Cardiovasc Imaging 2009;2:319-26. https://doi.org/10.1016/j.jcmg.2008.12.010
  9. Cho IJ, Chang HJ, Park HB, et al. Aortic calcification is associated with arterial stiffening, left ventricular hypertrophy, and diastolic dysfunction in elderly male patients with hypertension. J Hypertens 2015;33:1633-41. https://doi.org/10.1097/HJH.0000000000000607
  10. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002;40:1531-40. https://doi.org/10.1016/S0735-1097(02)02164-2
  11. Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997;30:260-311. https://doi.org/10.1016/S0735-1097(97)00150-2
  12. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015;28:1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003
  13. Frohlich ED, Susic D. Pressure overload. Heart Fail Clin 2012;8:21-32. https://doi.org/10.1016/j.hfc.2011.08.005
  14. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 2008;21:500-8. https://doi.org/10.1038/ajh.2008.16
  15. Arnett DK, de las Fuentes L, Broeckel U. Genes for left ventricular hypertrophy. Curr Hypertens Rep 2004;6:36-41. https://doi.org/10.1007/s11906-004-0009-5
  16. de Simone G, Izzo R, De Luca N, Gerdts E. Left ventricular geometry in obesity: is it what we expect? Nutr Metab Cardiovasc Dis 2013;23:905-12. https://doi.org/10.1016/j.numecd.2013.06.012
  17. Cacciapuoti F. Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives. J Am Soc Hypertens 2011;5:449-55. https://doi.org/10.1016/j.jash.2011.08.006
  18. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83:1849-65. https://doi.org/10.1161/01.CIR.83.6.1849
  19. Eren M, Gorgulu S, Uslu N, Celik S, Dagdeviren B, Tezel T. Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both. Heart 2004;90:37-43. https://doi.org/10.1136/heart.90.1.37
  20. Tsioufis C, Chatzis D, Dimitriadis K, et al. Left ventricular diastolic dysfunction is accompanied by increased aortic stiffness in the early stages of essential hypertension: a TDI approach. J Hypertens 2005;23:1745-50. https://doi.org/10.1097/01.hjh.0000174394.57644.69
  21. Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003;107:714-20. https://doi.org/10.1161/01.CIR.0000048123.22359.A0
  22. Kim J, Budoff MJ, Nasir K, et al. Thoracic aortic calcium, cardiovascular disease events, and all-cause mortality in asymptomatic individuals with zero coronary calcium: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 2017;257:1-8. https://doi.org/10.1016/j.atherosclerosis.2016.12.012
  23. Kim HK, Kim YJ, Hwang SJ, et al. Hemodynamic and prognostic implications of net atrioventricular compliance in patients with mitral stenosis. J Am Soc Echocardiogr 2008;21:482-6. https://doi.org/10.1016/j.echo.2007.08.024
  24. Kim TJ, Han DH, Jin KN, Won Lee K. Lung cancer detected at cardiac CT: prevalence, clinicoradiologic features, and importance of full-field-of-view images. Radiology 2010;255:369-76. https://doi.org/10.1148/radiol.10091083

Cited by

  1. Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication vol.51, pp.12, 2017, https://doi.org/10.4070/kcj.2021.0995
  2. Thoracic Aortic Calcification and Pre-Clinical Hypertension by New 2017 ACC/AHA Hypertension Guidelines vol.11, pp.6, 2017, https://doi.org/10.3390/diagnostics11061027